Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2011 Apr 6;108(17):7125–7130. doi: 10.1073/pnas.1019389108

Alternative mechanisms of receptor editing in autoreactive B cells

Olga Kalinina a, Colleen M Doyle-Cooper a, Jennifer Miksanek a, Wenzhao Meng b, Eline Luning Prak b, Martin G Weigert a,1
PMCID: PMC3084116  PMID: 21471456

Abstract

Pathogenic anti-DNA antibodies expressed in systemic lupus erythematosis bind DNA mainly through electrostatic interactions between the positively charged Arg residues of the antibody complementarity determining region (CDR) and the negatively charged phosphate groups of DNA. The importance of Arg in CDR3 for DNA binding has been shown in mice with transgenes coding for anti-DNA VH regions; there is also a close correlation between arginines in CDR3 of antibodies and DNA binding. Codons for Arg can readily be formed by V(D)J rearrangement; thereby, antibodies that bind DNA are part of the preimmune repertoire. Anti-DNAs in healthy mice are regulated by receptor editing, a mechanism that replaces κ light (L) chains compatible with DNA binding with κ L chains that harbor aspartic residues. This negatively charged amino acid is thought to neutralize Arg sites in the VH. Editing by replacement is allowed at the κ locus, because the rearranged VJ is nested between unrearranged Vs and Js. However, neither λ nor heavy (H) chain loci are organized so as to allow such second rearrangements. In this study, we analyze regulation of anti-DNA H chains in mice that lack the κ locus, κ-/κ- mice. These mice show that the endogenous preimmune repertoire does indeed include a high frequency of antibodies with Arg in their CDR3s (putative anti-DNAs) and they are associated mainly with the editor L chain λx. The editing mechanisms in the case of λ-expressing B cells include L chain allelic inclusion and VH replacement.

Keywords: autoimmunity, tolerance


Anti-DNA antibodies bind DNA mainly through electrostatic interactions between the positively charged Arg (R) residues of the antibody complementarity determining regions (CDRs) and the negatively charged DNA phosphodiester backbone (1). Arg enrichment has been demonstrated in the protein sequences of anti-DNA antibody heavy (H) chains (2, 3). In addition, reverse mutagenesis of an H chain Arg to a germline amino acid weakened DNA binding, whereas forward mutagenesis with additional Arg residues enhanced DNA binding (1). The predominant occurrence of Arg residues in the VH-encoded CDRs of anti-DNA antibodies indicates a dominant role for VH in DNA binding, and the DNA specificity of these H chains persists when paired with a wide variety of light (L) chains (46). There are exceptional L chains (4 Vκ L chains of 95 functional Vκ genes and 1 Vλ L chain of 4 functional Vλ L chains) of the mouse that modify or veto the DNA-binding quality of Arg-enriched H chains (4, 7, 8). These editor L chains are characterized by a high content of aspartate, a negatively charged amino acid that efficiently neutralizes the positively charged Arg residues of anti-DNA H chains (4). B cells that express an anti-DNA VH with a noneditor L chain can undergo further L chain rearrangement. If the original L chain is replaced by an editor L chain, the B cell will be tolerized (4, 7). Similarly, MHC class I-reactive B cells (found in 3–83μ transgenic mice) that encounter autoantigen in the bone marrow continue rearrangement and change receptor specificity by replacing the transgenic 3–83 κ L chain with an endogenous κ or λ L chain (9, 10).

Here we wished to evaluate the extent to which editor L chains rescue B cells with endogenous H chains. Given the clear evidence for H chains influencing the expressed L chain repertoire, we now examine whether and to what degree L chains can also influence the H chain repertoire. To do so, we studied mice with a normal germline H chain locus and a simplified L chain locus resulting from targeted deletion of the κ locus (11). These mice have a simple VL repertoire with only four possible λ L chains: three noneditors, λ1, λ2, and λ3 (encoded by three possible combinations of Vλ1 or Vλ2 with available JCλ segments, referred to collectively as λ1,2,3), are nearly identical and one editor, λX (VλX recombined to JCλ2; Fig. S1), which is only 50% identical to the λ1,2,3 class (12). λX is one of the most acidic L chains (pI 4.62) and λ1,2,3 are among the most basic (pI 10.9) (13). λX efficiently vetoes DNA binding by the interaction of Asp with the basic amino acids of anti-DNA VHs. We found evidence for L chain influence on the VH repertoire by comparing VHs expressed in B cells that express the editor λX chain to those that express the noneditor λ1,2,3 chains. We have analyzed the repertoire of λ-associated antibodies and found that the editing mechanisms in the case of λ-expressing B cells include L chain allelic inclusion and VH replacement.

Results

Editing Shapes the VH Repertoire.

In DNA-binding antibody H-chain transgenic models such as 56R, editing yields a population limited to L chains that modify the specificity of an anti-DNA VH (4). These edited antibodies either avoid binding self-antigen or bind DNA with low affinity [3H9/Vκ8 (14)]. Here, we studied the converse, namely the influence of the L chain on the endogenous VH repertoire. To test whether B cells expressing an editor L chain have a distinct repertoire of H chains, we compared the VH repertoire of B cells that expressed editors to those that express noneditor L chains. To quickly assess whether we would see a detectable difference in λ use that would reveal the kinds of repertoire effects of L chains that we planned to assess at a molecular level, we examined editor vs. noneditor λ L chain use in κ-/κ- mice compared with 56R κ-/κ- mice by flow cytometry. A clear alteration in the B-cell repertoire is evident based on a shift in the ratio of λX:λ1 from 9:1 in 56R κ-/κ- to 1:9 for λX:λ1,2,3 in κ-/κ- mice (Fig. 1). In this example, the 56R H chain is mainly associated with the editor L chain λX (13).

Fig. 1.

Fig. 1.

L chain isotype use in B6 wild-type (Left), B6 κ-/κ- (Center), and 56R B6 κ-/κ- (Right) mice. Splenocytes were stained with PE/Cy7 anti-B220, Alexa-647, anti-λX specific monoclonal antibodies (kindly provided by P.A. Cazenave (57)] and FITC-anti-λ1,2,3-monoclonal antibodies for B6 wild-type and B6 κ-/κ- and PE anti-λ1 antibody (L22.18.2, kindly provided by U. Storb) for 56R B6 κ-/κ- plots. The dot plots display λ1,2,3 for Left and Central panels and λ1 only for the Right panel (y axis) vs. λX expression (x axis) on cells in the live, lymphoid, B220+ gate.

The λ chains expressed in splenic B cells of the κ-/κ- mouse were unevenly distributed between λX (∼10%) and λ1,2,3 (∼84%) (Fig. 1). In addition, there was a small fraction of cells (2%) in the quadrant expected for B cells that coexpress λ1,2,3 and λX. We next used monoclonal antibodies specific for each Vλ to sort single Vλ1,2,3- and VλX-expressing B cells and study their VH repertoires in single B cells. We predicted that the λX population would be enriched in VHs that bind DNA.

VH Repertoires in λX and λ1,2,3 B Cells.

To compare the VH repertoires of λX and λ1,2,3 B cells, single-cell reverse transcription-PCR was followed by sequencing to identify the H and L chain genes in each of 303 FACS-sorted single cells (Fig. 2 and Fig. S2). The relative frequency of each VH family was calculated as a percentage of the total number of VH sequences within each population of cells as defined by L chain expression. The VH repertoires were similar to each other with respect to gene family use (Fig. 2) and resembled the previously described repertoire of wild-type mice (15). The VH families VHJ558, VH7183, VHQ52, VH9, VH10, VH36–60, and VH3609 were represented in equal proportions in both populations. Further, there were several examples of the same VH gene being rearranged in B cells expressing either the editor λX or the noneditor L chain (λ1).

Fig. 2.

Fig. 2.

VH gene family use in the splenic B cells expressing editor (λX, dark bars) and noneditor (λ1,2,3, light bars) L chains from B6 κ-/κ- mice as determined by single cell reverse transcription-PCR. VH use is depicted as the relative frequency of each VH gene family among all analyzed VH sequences within each sorted population. N = 215 (100%) for λX and N = 88 (100%) for λ1,2,3. VH genes that were found only in λX antibodies are indicated with asterisk (*).

There were exceptions: two VH families (J606 and S107) were observed only among λX in this survey (Fig. 2). The frequency of J606 use is significantly different in λX vs. λ1,2,3 B cells (P ∼0.0002, see SI Results). Furthermore, among the 20 unique J606 sequences, 16 used the VHJ606.1 gene segment, and the remainder used VHJ606.4. Restricted VH/VL associations have been explained by positive selection upon the specificity (presumably anti-self) formed by the H + L chain pair (1618), but preferential association of particular H chains with λX could also be explained by negative selection. For example, if the combinations of VH from J606 with λ1,2,3 L chains were autoreactive, then B cells with these combinations would be deleted or edited.

To further evaluate the influence of the L chain on the repertoire of VHJ606.1, we performed CDR3 spectratyping on VHJ606.1-JH2 rearrangements in the genomic DNA of five different subsets of B cells: λX and λ1,2,3 from B6 κ-/κ-, λ and total splenocytes (∼95% κ+) from B6, and total splenocytes from B6.Vκ8+/−. By analyzing genomic DNA, we are able to measure the fraction of rearrangements that are in-frame, which is correlated with selection of individual VHs (19). Thus, if the manner of VHJ606.1 selection is distinctive with different L chains, then we expect to find differences in the fraction of rearrangements that are in-frame. As shown in Fig. S3, this is indeed the case. The fraction of in-frame VHJ606.1-JH2 rearrangements in λX B cells from κ-/κ- mice was 100% (23/23 rearrangements), whereas the corresponding fraction in λ1,2,3 B cells from κ-/κ- mice was 73% (P < 0.01 by Fisher exact test exact test). The fraction of in-frame rearrangements is intermediate in B-cell populations from λ or total splenocytes from B6, and total splenocytes from B6.Vκ8+/− mice.

Another example of selection for a particular VH gene is VHSM7.4. Although the SM7 family was represented in both the λX and λ1,2,3 populations, VH gene use and CDR3 sequences were very distinct. Nine of 14 independent SM7 sequences from λX-expressing B cells expressed the same VH family member, SM7.4, which was not found in the sampling of λ1,2,3 antibodies in our survey. Moreover, seven of nine SM7.4 sequences had similar CDR3s with respect to length and polarity, both of which are ordinarily highly variable properties of CDR3s (Fig. 3). CDR3 similarity could be dictated by the SM7.4 VH sequence. The SM7.4 VH encodes negatively charged residues Asp and Glu at CDR1 and CDR2. A strongly negatively charged CDR2 is likely to bind positively charged antigens. Indeed, the SM7.4 VH has been shown to bind Sm (20). Short and Arg-rich CDR3s could be the result of editing in response to self-reactivity. Alternatively, a combination of VHSM7.4 with a short, positively charged CDR3 and λX could be positively selected by some unknown (self) antigen.

Fig. 3.

Fig. 3.

VH family Sm7 gene use and VH CDR3 amino acid sequences of H chains in B cells sorted on the basis of L chain expression and expressed with editor (VλX), noneditor (Vλ1,2,3), or both (Vλ1,2,3/VλX) L chains from B6 κ-/κ- mice. Args in each CDR3 are highlighted in red.

CDR3 Sequences of λX and λ1,2,3 Antibodies.

The correlation of antibody specificity and selection is apparent from the difference in the frequency of Arg residues in the CDR3s of VHs expressed with editor or noneditor L chain (Table 1 and Fig. S3A). There are 119 Args of 2058 VH CDR3 residues in λX antibodies (6% of the total amino acid content of CDR3), significantly more than the 16 Args of 875 VH CDR3 residues (2%) in λ1,2,3 antibodies (P < 0.00001; χ2 test). The pool of known VH CDR3 sequences allows us to compare the frequency of Arg residues in the VH CDR3 regions of λX- and λ1,2,3-encoded antibodies to VHs expressed with a variety of L chains (Table 1). There are 3,003 Args in 74,923 CDR3 residues in the Abysis database (http://www.bioinf.org.uk/abs/), which represents an Arg content of 4% in the known mouse H chain repertoire [it was 105 Args of 3,066 residues (3.4%) in the Kabat et al. (2) compilation 20 y ago when we originally made this observation]. Thus, λX antibodies have a significantly higher level (P = 0.0001; χ2 test) of VH CDR3 arginines compared with sequences from the total recorded mouse antibody sequences.

Table 1.

Arg content in VH CDR3 regions of λx- and λ1-encoded Abs and Abs from total recorded mouse B cell repertoire

Total CDR3 amino acids Args % of Args
Abysis database 74,923 3,003 4
B cells expressing λx 2,058 119 5.8
B cells expressing λ1,2,3 875 16 1.8

Numbers of total amino acids and arginine residues in VH CDR3s were calculated through analysis of 215 and 88 VH sequences from λX- and λ1,2,3- expressing B cells, respectively (CDR3 sequences are provided in Fig. S2). Numbers for total recorded mouse antibodies were obtained from Abysis database (http://www.bioinf.org.uk/abs/). The CDR3 regions were identified according to the convention of Kabat et al. (59), where CDR3 includes amino acids at positions H95–H102. The percentage of Arg in VH CDR3s was calculated as the ratio of the number of Arg residues in CDR3s from all VH sequences of each group to the total number of amino acids in CDR3s of all VH sequences from each group multiplied by 100.

Mechanisms That Generate Arg Codons in CDR3 Regions.

Several mechanisms can contribute to the generation and diversity of CDR3 regions, including alternative DH reading frames (RF), D-D fusions, imprecise joining at the DJ and VD junctions, and N and P addition. We examined the contributions of these mechanisms to the formation of Arg codons in the CDR3 regions of H chains paired with λX or λ1,2,3 L chains in our sorted cells.

The reading frame of DH genes can vary. Further, DH genes can be rearranged in either transcriptional orientation, which provides three additional reading frames. However, CDR3 sequences are encoded by a preferred DH reading frame and DH genes are usually rearranged to JH at their 3′ recombination signal sequence (RSS) (21, 22). Here, we found that the majority of DH genes were read in RF1: 74% and 66% for λ1,2,3 and λX B cells, respectively. These frequencies are similar to those reported for normal newborn and adult mice (21, 22). Reading frame usage could account for the CDR3 Arg bias, because Arg codons are overrepresented in reading frames usage other than RF1. In fact, when their DH gene segments are read in RF2 or RF3, 43% and more than 50% of H chains have Args in the CDR3 region in λ1,2,3 and λX B cells, respectively, whereas in RF1 this number drops to 21% (in λ1 cells) and 31% (in λX cells). Restricted reading frame use has been attributed to rearrangement requirements such as the translational competence of DHJH rearranged genes (Dμ) read in RF2 and the abundance of stop codons in RF3 (23). Our data favor an alternative explanation that CDR3 sequences predominantly use the first RF, because RF1 disfavors Arg codons so that more B cells using this RF survive the selection process (24). Selection against Arg in CDR3 may result from the association between CDR3 Arg and DNA binding.

D-D fusion can generate arginines in VH CDR3 regions. D-D fusions can contribute more reading frame choices, thereby increasing the likelihood of Arg codons. Fusions also provide additional opportunities for N and P addition at the junction of the fusion. Direct fusions, those that lack N or P addition, can form Arg codons made up of 5′ and 3′ nucleotides from two Ds. To identify D gene fusions, we first searched for multiple D segments in each CDR3 from our data set. We found that 8–10% of the H chains in our survey contained a D-D fusion (Fig. S4) in both λX- and λ1,2,3-expressing B cells. Ten of 21 H chain sequences with evidence of D-D fusion also exhibited CDR3-encoded arginine residues (Fig. S4).

λ1,2,3/λX Double-Expression Occurs with VH Genes That Exhibit Anti-DNA Features.

Receptor editing at the κ locus is replacement of a VκJκ that contributes to autoreactivity by leapfrogging rearrangement of a nonautoreactive VκJκ or by inactivation via rearrangement of the recombination signal (RS) to the κ-locus intronic recombination signal 1 (iRS1) or RS sequences 3′ of Jκs or Vκ, respectively (Fig. S1) (25, 26). The structure of the murine λ locus, however, does not support leapfrogging or RS deletion. Therefore, editing of autoreactive B cells in the κ-/κ- mouse or among λ-expressing B cells in B6 mice may require alternative mechanisms. Ongoing rearrangement stimulated by autoreactivity (9, 27) allows a B cell to express another L chain from the λ locus, but this new rearrangement does not inactivate previous autoreactive rearrangements. As such, the consequence of editing in κ-/κ- mice would likely be isotypic and/or allelic inclusion, leading to the expression of two different antibodies, one of which is the original autoreactive antibody. These κ/λ or κ/κ “allelically included” B cells are thought to be inactive (28) or sequestered (29). This form of editing may be represented by the population of isotypically included λ1/λX B cells in 3H9 and 56R κ-/κ- mice (Fig. 1). In fact, the 3H9 κ-/κ- and 56R κ-/κ- mice have twice as many λ1,2,3/λX double-expressing B cells as nontransgenic (nontg) κ-/κ- mice (Table 2 and Fig. 1).

Table 2.

The frequencies of different λ rearrangements in splenic B cells from κ-sufficient and κ-/κ- mice and in LPS hybridomas from different lines of κ-/κ- mice

Hybridomas Flow cytometry data
λ genotype Nontg.κ-/κ-, N (%) 3H9.κ-/κ-, N (%) 56R.κ-/κ-, N (%) B6 (%) B6.κ-/κ- (%)
λ1,2,3 115 (92) 23 (22) 26 (29) (4.9) (84)
λx 5 (4) 40 (38) 35 (39) (0.8) (10)
λ1,2,3/λx double 5 (4) 42 (40) 29 (32) (0.05) (2)
Total 125 105 90 (5.75) (96)

The frequencies of different λ rearrangements were evaluated as a percentage of the live B220+ lymphocytes by flow cytometric analysis of splenocytes from B6.κ-/κ- and B6 mice. Shown for comparison are previously published data from hybridoma panels from 3H9.κ-/κ-, 56R.κ-/κ-, and nontg κ-/κ- mice (13; data from ref. 60, copyright 1994, Rockefeller University Press). κ-/κ- refers to homozygous κ-deficiency. Numbers of hybridomas are given; all percentage data are given in parentheses.

To obtain direct evidence that isotypically included (λ1,2,3/λX) B cells are edited cells, we sorted λ1,2,3/λX double-positive B cells and analyzed the H chain sequences from 57 single B cells. As was shown above, H chains of B cells expressing editor (λX) and noneditor (λ1,2,3) L chains are different with regard to Arg content in CDR3. We reasoned that if isotypically included (λ1,2,3/λX) B cells are edited, then the H chain CDR3s in these cells should resemble CDR3s of H chains typically paired with the editor λX. Alternatively, if the combination of anti-DNA H chain and λ1,2,3 does not represent an edited population, then the H chain CDR3s of isotypically included B cells should more closely resemble the CDR3s of H chain from λ1,2,3 B cells.

Our data indicate that isotypically included B cells express broad VH gene family repertoire similar to that of λ1,2,3- or λX-only antibodies as well as to antibodies from wild-type mice (15). However, VHs from J606 and S107 families, which were found only in λX B cells in our survey, were also found in B cells expressing two L chains (λ1,2,3/λX). The Arg content in CDR3 sequences of allelically included B cells (λ1,2,3/λX) was significantly higher than that in λ1,2,3 B cells (4.5 vs. 1.8%, respectively; P = 0.01; χ2 test), indicating that included B cells are likely to be edited cells.

Editing at VH.

Another potential substrate for editing in the κ-/κ- mice is the H chain locus. Complete V(D)J rearrangements are not nested between “functional” (12/23) RS sequences as in the κ locus, because all DH segments are deleted during primary V(D)J rearrangement. However, the VH gene segment of most H chains can be replaced (edited) by an upstream VH (3035). In these cases, an upstream VH can be rearranged to a cryptic recombination signal sequence (cRSS, or embedded heptamer), located near the 3′ end of the coding region of the originally rearranged VH gene (Fig. 4A). The original VH region is thus replaced by a new VH gene except for a short stretch of nucleotides (footprint), located downstream of the embedded heptamer. The recipient CDR3 and JH are preserved, but additional nucleotides are added to the 5′ end of the CDR3 from the 3′ end of donor VH gene, the footprint left over from 3′ end of recipient VH gene and P-nucleotides and N addition (36). In addition, nucleotides of the footprint and the 5′ end of CDR3 can be deleted, because the cleavage at the heptamer leaves this sequence unprotected and subject to exonuclease digestion [referred to as chopping (37)]. Here, we defined footprints as five or more consecutive nucleotides of identity with a different VH from the upstream VH as evidence of VH replacement.

Fig. 4.

Fig. 4.

VH replacement footprints. (A) Schematic representation of VH replacement. White triangles represent RS sequences. Dark triangles represent the cRSS or embedded heptamer. The green region represents a rearranging VH (donor) that replaced the initially rearranged VH (recipient, magenta) and joined to the short stretch of nucleotides (footprint, magenta) that remained after the recipient VH was cleaved at cRSS. (B) Potential VH replacement products were found among H chain sequences from splenic B cells from κ-/κ- mice. Donor VH refers to the VH gene segment fully represented in the complete V(D)J sequence. The nucleotide sequences shown are the end of the VH donor sequence and the N1 nucleotides located between the last nucleotide of framework 3 and the first D nucleotide. Potential VH replacement footprints are defined as 5 or more consecutive nucleotides of identity with the 3′ end sequence of a nondonor germline VH and are highlighted in magenta. Possible recipients are germline VHs whose 3′ end sequence contains the footprint sequence found in the VH replacement product. The amino acids shown are from the VH CDR3. P nucleotides are in parentheses.

Among the 240 analyzed VH sequences, 18 (7.5%) had identifiable VH replacement footprints (Table 3 and Fig. 4B). Fifteen of the 18 (83%) VH replacement products replaced a nonfunctional original V(D)J rearrangement, whereas 17% of the VH replacement products replaced a functional original V(D)J. Assuming the latter are the result of editing, we concluded there was evidence of editing by VH replacement in 3 of 240 (1%) examined H chains. Considering that VH replacement footprints can be shortened or eliminated during VH replacement, this may be an underestimation. It was shown in knockin mice homozygous for a nonproductive IgH rearrangement that, of all of the functional H chains generated through VH replacement, only 20% of the functional replacement products contained a VH replacement footprint (37). Moreover, VH replacement can lead to both productive and nonproductive rearrangements; therefore, the rate of VH replacement may be substantially higher than the number of identifiable VH replacement products. To test if VH replacement is the unique property of κ-/κ- mice, we analyzed the frequency of the potential VH replacement products in IgH sequences from the wild-type B6 κ-sufficient mouse and found it to be ∼6% (9/157; Fig. S5).

Table 3.

Number of potential VH replacement footprints in V-D and footprint-like sequences in D-J regions

Total B cells λX λ1
No. of sequences analyzed 240 178 62
No. of sequences with footprints in V-D (N1) 18 (7.5%)* 14 (8%) 4 (6%)
Footprint-like sequences in D-J (N2) 4 (2%) 3 (2%) 1 (2%)
Replacements of IF VHs 3 (17%) 2 (14%) 1 (25%)

The number of potential VH replacement footprints is shown for total analyzed H chain sequences (only VHs with identified DH regions were analyzed) and separately for λx and λ1,2,3 antibodies. The number of footprints in the N1 region was significantly higher than the number of footprint-like sequences in the N2 region (*P = 0.001, χ2 test). The number of VH replacement products that are the result of replacing of in-frame (IF) V(D)J rearrangements is indicated for all groups.

Short footprint lengths combined with the fact that there are only four nucleotides makes it difficult to determine whether a footprint is actually a remnant of the recipient VH or the result of N or P nucleotide addition. To verify that these sequences represent bona fide footprints, we compared the number of footprints in the V-D junction (N1) and in the D-J junction (N2), as was previously described by Zhang et al. (36). The rationale for this comparison is that nucleotide sequences in both V-D and D-J are created by the same mechanisms, namely N and P addition, and if these mechanisms can create sequences that look like footprints, such sequences should be created in both locations. We found that 18 of 240 H chain sequences (7.5%) contain VH replacement footprints at the V-D junction and 4 of 240 (2%) have footprint-like sequences in the D-J region (P = 0.002) (Table 3). Similar percentages have been shown by Zhang and Collins (36, 38); however, this reasoning may not apply to every VH gene (39).

Another way to test whether these sequences represent true footprints is to determine whether the donor VH is located upstream of the putative recipient VH. All 18 possible products of VH replacement passed this test. For two sequences with footprints we were not able to find the possible recipient; these sequences were not included in the pool of 18 possible VH replacement products. Therefore, we conclude that most footprints at V-D junctions are contributed by VH replacement.

Discussion

Receptor editing is a process of ongoing rearrangement following an initial rearrangement event in developing and/or autoreactive B cells. Studies of receptor editing in anti-DNA transgenic mice have shown that anti-DNA H chains are absent from the mature B-cell repertoire unless paired with an editor L chain (4). Does this observation apply to endogenous anti-DNA B-cell receptors that arise in a nontransgenic system, and if so, then how frequently do anti-DNA cells occur in a normal repertoire? To test this, we separated B cells into fractions that express either editor or noneditor L chains and compared the VH repertoire in the two populations.

We used mice without κ L chains [κ-/κ- (11)], which have a simple VL repertoire consisting of one editor (λX) and three noneditor (λ1,2,3) L chains. Assuming that B cells are formed with a wide diversity of VH rearrangements at the pre-B-cell stage and go on to have an equal probability of association with one of the four Vλ/Cλ combinations as they progress through development, the VH repertoire should be randomly distributed between λ1,2,3 and λX. However, we found that VH sequences differed between the two populations: the B-cell population expressing the editor L chain (λX) contained a greater proportion of cells expressing antibodies with Arg residues in the VH CDR3 than did the population of noneditor-expressing (λ1,2,3) B cells (40% vs. 12%, respectively). Because VHs that are enriched in Arg residues are likely to bind DNA, these results suggest that the endogenous VH repertoire includes a high frequency of B cells with the potential to bind DNA. Although there is a strong correlation between the presence of Arg residues and DNA binding, we do not know whether it is a strict correlation. Ongoing experiments are testing this question. Here, we are mainly concerned with Arg frequencies and how they differ in the λX and λ1,2,3 populations. The presence of antibodies enriched in Arg content in the λX compartment shows that B cells expressing endogenous VH repertoires require receptor editing and that editing is not restricted to (or an artifact of) B cells expressing transgenic anti-DNA VHs. A similar conclusion was reached in studies of κ-macroself transgenic mice (40).

Our analysis shows that the frequency of VHs with Arg in CDR3 in λ1,2,3-expressing B cells is lower than in λX-expressing B cells. How can we account for the lower frequency of VHs with Arg in CDR3 in the λ1,2,3 population? If Arg-enriched VH + λ1,2,3 combinations are autoreactive, as in the case of 3H9/λ1, cells bearing these antibodies may have been edited. However, this conclusion bears the caveat that the editing mechanism(s) used by the κ locus is not available to κ-/κ- mice. The κ-/κ- B cells cannot edit autoreactive receptors unless they use alternative (non-κ) mechanisms of editing.

An Alternative Mechanism of Editing: Allelic Inclusion.

The only known way of editing the L chain locus in a κ-/κ- mouse is by secondary λ rearrangement, thereby forcing a B cell to allelic and/or isotypic inclusion, exemplified by λ1,2,3/λx-double-expressing B cells. Lymphocytes with two L chains have been described in transgenic and normal mice (28, 29, 4143). Among anti-DNA B cells from Ig transgenic mice, allelically included B cells usually coexpress an editor L chain, implying that these B cells must be the result of editing. In the κ-/κ- mouse, we identified and characterized a population of B cells that coexpress λ1,2,3 and λX. In this population, as in the λX-only population, we found a high frequency of VHs that have Arg in CDR3 (32%). Thus, the normal B-cell repertoire contains cells edited by isotypic inclusion.

Another Alternative Mechanism of Editing: VH Replacement.

Secondary rearrangement can also replace rearranged H chain genes. Originally discovered in B-cell lines (30, 32, 44), VH replacement was subsequently demonstrated in Ig knockin mice (34, 45). Based on the footprints of replacement, VH genes that have been replaced have been estimated to comprise 5–12% of the human H chain repertoire (36). Here, we found VH replacement footprints in 7.5% of all analyzed H chain sequences in κ-/κ- mice and a similar frequency in VH rearrangements cloned from B6 spleen DNA. VH replacement may play a physiological role in B-cell repertoire diversification based upon the conservation of the embedded RSS sequence in most murine and human VH genes (34). Recently, it was reported that cattle VH segments have conserved nucleotide sequences (CSNS) comprising 13–18 nt located at the VH-DH junction (46). These sequences belong neither to the rearranged VH nor to any known cattle DH genes. They are too long and are not GC-rich enough to be N nucleotides, nor are they palindromic. They could be VH replacement footprints. Furthermore, cattle CSNS are rich in A nucleotides (46), a characteristic of footprints in murine and human H chains.

Despite the contradictory evidence regarding the frequency of VH replacement as an editing mechanism, VH replacement is not very efficient (37, 4750). It adds charged amino acids (most often Arg) to the VH CDR3 and, like conventional rearrangement, can generate nonproductive rearrangements. However, deletion of anti-DNA H chains by nonproductive VH replacement represents a form of editing analogous to κ deletion and may allow rearrangement to occur at the other H chain locus (51).

Methods

Mouse Breeding.

Nonautoimmune homozygous κ knockout C57BL/6 (B6 κ-/κ-) mice (11) were purchased from GenPharm International. 56R site-directed transgenic mice (4) were crossed to homozygous κ-/κ- mice to produce 56R/ κ-/κ- mice. Tail DNA samples of 56R, Vκ8, and κ-/κ- mice were genotyped as described previously (4, 52, 53). C57BL/6J (B6) mice were purchased from The Jackson Laboratory. Presence of anti-DNA and antinuclear antibodies was analyzed by ELISA (54) and ANA (BION) using sera from B6 κ-/κ- and B6 mice (n = 5 mice per group). Mice used for these experiments were 6–12 wk old. All animal procedures were conducted in accordance with the guidelines and regulations of the University of Chicago IACUC.

Flow Cytometry.

Splenocytes were isolated from κ-/κ- (n = 5), 56R κ-/κ- (n = 5), and wild-type (n = 5) mice, all on the B6 background. B cells expressing λ1, λ2, or λ3 were identified with fluorescein isothiocyanate (FITC)-labeled anti-mouse Ig λ1,2,3 mAb (clone R26-46, Pharmingen). λ1-only cells were stained with monoclonal phycoerythrin (PE)-labeled anti-λ1 antibody [clone L22.18.2, kindly provided by U. Storb (University of Chicago, Chicago) (55, 56)]. B cells expressing λX were identified with Alexa–Fluor647-conjugated anti-VλX monoclonal antibody (10C5) specific for the VλX gene segment [kindly provided by P. A. Cazenave (Pasteur Institute, Paris) (57)]. For the B-cell gate, PE-Cy7-labeled CD45R/B220 antibody (RA3-6B2, 1:400, Pharmingen) was used. Fluorescence analysis was performed on a FACS Canto (BD Biosciences) with DiVa software (BD Biosciences) and analyzed with FlowJo software (Tree Star, Inc.).

Cell Sorting and H Chain Amplification.

Single cell sorting of B220+λX+ cells and B220+λ1,2,3+ cells followed by reverse transcriptase-PCR was performed as described previously (58). VH genes from single cells were amplified using a degenerate H chain (FR1) sense primer VH5.3 (34) and antisense Cμ primers (IgMc1st 5′-GAAGGAAATGGTGCTGGGGAGCAGGAA-3′ and IgMc2nd 5′-GACAGGGGGCTCTCGCAGGA-3′). VL genes were amplified with Vλ1,2,3 primers (54) and VλX primers (sense: λX-L 5′-ATGGCCTGGACTCCTCTCTTCT-3′; λX -64 5′-TGCACCTTGAGTAGTCAGCACAGT-3′ and antisense λXR1 5′- CTGGACAGTGACCTTGGTT-3′; λ XR2 5′-GTTCCACCGCCGAAAACATA-3′. PCR products were sequenced at the University of Chicago sequencing core. H and L chain genes were identified using IgBLAST (http://www.ncbi.nlm.nih.gov/igblast/) and IMGT/V-quest (http://www.imgt.org/IMGT_vquest/share/textes/).

CDR3 Spectratyping.

Spectratyping protocol is given in SI Methods.

Statistical Analysis.

For statistical analysis, a χ2 test and a Fisher exact test were performed. Calculations were performed using GraphPad software (Prism) and applets (http://www.graphpad.com/quickcalcs).

Supplementary Material

Supporting Information

Acknowledgments

We thank Cindy Benedict-Alderfer (http://www.cbascience.com) for her help editing the manuscript. This work was supported by National Institutes of Health Grants 5R01GM020964-34 and R01 DE012590 and the Lupus Research Institute.

Footnotes

The authors declare no conflict of interest.

Data deposition: The sequences reported in this paper have been deposited in the NCBI GenBank database (accession nos. JF690280JF690665).

This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1019389108/-/DCSupplemental.

References

  • 1.Radic MZ, et al. Residues that mediate DNA binding of autoimmune antibodies. J Immunol. 1993;150:4966–4977. [PubMed] [Google Scholar]
  • 2.Shlomchik M, et al. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med. 1990;171:265–292. doi: 10.1084/jem.171.1.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Radic MZ, et al. Structural patterns in anti-DNA antibodies from MRL/lpr mice. Cold Spring Harb Symp Quant Biol. 1989;54:933–946. doi: 10.1101/sqb.1989.054.01.108. [DOI] [PubMed] [Google Scholar]
  • 4.Li H, Jiang Y, Prak EL, Radic M, Weigert M. Editors and editing of anti-DNA receptors. Immunity. 2001;15:947–957. doi: 10.1016/s1074-7613(01)00251-5. [DOI] [PubMed] [Google Scholar]
  • 5.Ibrahim SM, Weigert M, Basu C, Erikson J, Radic MZ. Light chain contribution to specificity in anti-DNA antibodies. J Immunol. 1995;155:3223–3233. [PubMed] [Google Scholar]
  • 6.Radic MZ, Ibrahim SM, Rauch J, Camper SA, Weigert M. Constitutive secretion of transgene-encoded IgG2b autoantibodies leads to symptoms of autoimmune disease. J Immunol. 1995;155:3213–3222. [PubMed] [Google Scholar]
  • 7.Gay D, Saunders T, Camper S, Weigert M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med. 1993;177:999–1008. doi: 10.1084/jem.177.4.999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Brekke KM, Garrard WT. Assembly and analysis of the mouse immunoglobulin kappa gene sequence. Immunogenetics. 2004;56:490–505. doi: 10.1007/s00251-004-0659-0. [DOI] [PubMed] [Google Scholar]
  • 9.Tiegs SL, Russell DM, Nemazee D. Receptor editing in self-reactive bone marrow B cells. J Exp Med. 1993;177:1009–1020. doi: 10.1084/jem.177.4.1009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Pelanda R, et al. Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification. Immunity. 1997;7:765–775. doi: 10.1016/s1074-7613(00)80395-7. [DOI] [PubMed] [Google Scholar]
  • 11.Chen J, et al. B cell development in mice that lack one or both immunoglobulin kappa light chain genes. EMBO J. 1993;12:821–830. doi: 10.1002/j.1460-2075.1993.tb05722.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sanchez P, Marche PN, Le Guern C, Cazenave PA. Structure of a third murine immunoglobulin lambda light chain variable region that is expressed in laboratory mice. Proc Natl Acad Sci USA. 1987;84:9185–9188. doi: 10.1073/pnas.84.24.9185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Doyle CM, Han J, Weigert MG, Prak ET. Consequences of receptor editing at the lambda locus: multireactivity and light chain secretion. Proc Natl Acad Sci USA. 2006;103:11264–11269. doi: 10.1073/pnas.0604053103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Radic MZ, Mascelli MA, Erikson J, Shan H, Weigert M. Ig H and L chain contributions to autoimmune specificities. J Immunol. 1991;146:176–182. [PubMed] [Google Scholar]
  • 15.Viale AC, Coutinho A, Freitas AA. Differential expression of VH gene families in peripheral B cell repertoires of newborn or adult immunoglobulin H chain congenic mice. J Exp Med. 1992;175:1449–1456. doi: 10.1084/jem.175.6.1449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Levine MH, et al. A B-cell receptor-specific selection step governs immature to mature B cell differentiation. Proc Natl Acad Sci USA. 2000;97:2743–2748. doi: 10.1073/pnas.050552997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hachemi-Rachedi S, Cumano A, Drapier AM, Cazenave PA, Sanchez P. Does positive selection determine the B cell repertoire? Eur J Immunol. 1997;27:1069–1074. doi: 10.1002/eji.1830270505. [DOI] [PubMed] [Google Scholar]
  • 18.Hachemi-Rachedi S, Drapier AM, Cazenave PA, Sanchez P. Affiliation to mature B cell repertoire and positive selection can be separated in two distinct processes. Int Immunol. 2000;12:385–395. doi: 10.1093/intimm/12.3.385. [DOI] [PubMed] [Google Scholar]
  • 19.Decker DJ, Kline GH, Hayden TA, Zaharevitz SN, Klinman NR. Heavy chain V gene-specific elimination of B cells during the pre-B cell to B cell transition. J Immunol. 1995;154:4924–4935. [PubMed] [Google Scholar]
  • 20.Bloom DD, et al. V region gene analysis of anti-Sm hybridomas from MRL/Mp-lpr/lpr mice. J Immunol. 1993;150:1591–1610. [PubMed] [Google Scholar]
  • 21.Feeney AJ. Lack of N regions in fetal and neonatal mouse immunoglobulin V-D-J junctional sequences. J Exp Med. 1990;172:1377–1390. doi: 10.1084/jem.172.5.1377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Chang Y, Paige CJ, Wu GE. Enumeration and characterization of DJH structures in mouse fetal liver. EMBO J. 1992;11:1891–1899. doi: 10.1002/j.1460-2075.1992.tb05241.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Reth MG, Alt FW. Novel immunoglobulin heavy chains are produced from DJH gene segment rearrangements in lymphoid cells. Nature. 1984;312:418–423. doi: 10.1038/312418a0. [DOI] [PubMed] [Google Scholar]
  • 24.Louzoun Y, Luning Prak E, Litwin S, Weigert M. D is for different-differences between H and L chain rearrangement. Semin Immunol. 2002;14:239–241. doi: 10.1016/s1044-5323(02)00052-0. [DOI] [PubMed] [Google Scholar]
  • 25.Durdik J, Moore MW, Selsing E. Novel kappa light-chain gene rearrangements in mouse lambda light chain-producing B lymphocytes. Nature. 1984;307:749–752. doi: 10.1038/307749a0. [DOI] [PubMed] [Google Scholar]
  • 26.Moore MW, Durdik J, Persiani DM, Selsing E. Deletions of kappa chain constant region genes in mouse lambda chain-producing B cells involve intrachromosomal DNA recombinations similar to V-J joining. Proc Natl Acad Sci USA. 1985;82:6211–6215. doi: 10.1073/pnas.82.18.6211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Radic MZ, Erikson J, Litwin S, Weigert M. B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med. 1993;177:1165–1173. doi: 10.1084/jem.177.4.1165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Huang H, Kearney JF, Grusby MJ, Benoist C, Mathis D. Induction of tolerance in arthritogenic B cells with receptors of differing affinity for self-antigen. Proc Natl Acad Sci USA. 2006;103:3734–3739. doi: 10.1073/pnas.0600214103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Li Y, Li H, Weigert M. Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med. 2002;195:181–188. doi: 10.1084/jem.20011453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kleinfield R, et al. Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly 1+ B-cell lymphoma. Nature. 1986;322:843–846. doi: 10.1038/322843a0. [DOI] [PubMed] [Google Scholar]
  • 31.Kleinfield RW, Weigert MG. Analysis of VH gene replacement events in a B cell lymphoma. J Immunol. 1989;142:4475–4482. [PubMed] [Google Scholar]
  • 32.Reth M, Gehrmann P, Petrac E, Wiese P. A novel VH to VHDJH joining mechanism in heavy-chain-negative (null) pre-B cells results in heavy-chain production. Nature. 1986;322:840–842. doi: 10.1038/322840a0. [DOI] [PubMed] [Google Scholar]
  • 33.Wilson PC, et al. Receptor revision of immunoglobulin heavy chain variable region genes in normal human B lymphocytes. J Exp Med. 2000;191:1881–1894. doi: 10.1084/jem.191.11.1881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Chen C, Nagy Z, Prak EL, Weigert M. Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity. 1995;3:747–755. doi: 10.1016/1074-7613(95)90064-0. [DOI] [PubMed] [Google Scholar]
  • 35.Pewzner-Jung Y, et al. B cell deletion, anergy, and receptor editing in “knock in” mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain. J Immunol. 1998;161:4634–4645. [PubMed] [Google Scholar]
  • 36.Zhang Z, et al. Contribution of Vh gene replacement to the primary B cell repertoire. Immunity. 2003;19:21–31. doi: 10.1016/s1074-7613(03)00170-5. [DOI] [PubMed] [Google Scholar]
  • 37.Koralov SB, Novobrantseva TI, Königsmann J, Ehlich A, Rajewsky K. Antibody repertoires generated by VH replacement and direct VH to JH joining. Immunity. 2006;25:43–53. doi: 10.1016/j.immuni.2006.04.016. [DOI] [PubMed] [Google Scholar]
  • 38.Collins AM, et al. Partitioning of rearranged Ig genes by mutation analysis demonstrates D-D fusion and V gene replacement in the expressed human repertoire. J Immunol. 2004;172:340–348. doi: 10.4049/jimmunol.172.1.340. [DOI] [PubMed] [Google Scholar]
  • 39.Ohm-Laursen L, Nielsen M, Larsen SR, Barington T. No evidence for the use of DIR, D-D fusions, chromosome 15 open reading frames or VH replacement in the peripheral repertoire was found on application of an improved algorithm, JointML, to 6329 human immunoglobulin H rearrangements. Immunology. 2006;119:265–277. doi: 10.1111/j.1365-2567.2006.02431.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Ait-Azzouzene D, et al. An immunoglobulin C kappa-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system. J Exp Med. 2005;201:817–828. doi: 10.1084/jem.20041854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Velez MG, et al. Ig allotypic inclusion does not prevent B cell development or response. J Immunol. 2007;179:1049–1057. doi: 10.4049/jimmunol.179.2.1049. [DOI] [PubMed] [Google Scholar]
  • 42.Casellas R, et al. Igkappa allelic inclusion is a consequence of receptor editing. J Exp Med. 2007;204:153–160. doi: 10.1084/jem.20061918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Liu S, et al. Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens. J Immunol. 2005;175:5067–5076. doi: 10.4049/jimmunol.175.8.5067. [DOI] [PubMed] [Google Scholar]
  • 44.Covey LR, Ferrier P, Alt FW. VH to VHDJH rearrangement is mediated by the internal VH heptamer. Int Immunol. 1990;2:579–583. doi: 10.1093/intimm/2.6.579. [DOI] [PubMed] [Google Scholar]
  • 45.Taki S, Schwenk F, Rajewsky K. Rearrangement of upstream DH and VH genes to a rearranged immunoglobulin variable region gene inserted into the DQ52-JH region of the immunoglobulin heavy chain locus. Eur J Immunol. 1995;25:1888–1896. doi: 10.1002/eji.1830250715. [DOI] [PubMed] [Google Scholar]
  • 46.Koti M, Kataeva G, Kaushik AK. Novel atypical nucleotide insertions specifically at VH-DH junction generate exceptionally long CDR3H in cattle antibodies. Mol Immunol. 2010;47:2119–2128. doi: 10.1016/j.molimm.2010.02.014. [DOI] [PubMed] [Google Scholar]
  • 47.Davila M, et al. Multiple, conserved cryptic recombination signals in VH gene segments: detection of cleavage products only in pro B cells. J Exp Med. 2007;204:3195–3208. doi: 10.1084/jem.20071224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Yunk L, Meng W, Cohen PL, Eisenberg RA, Luning Prak ET. Antibodies in a heavy chain knock-in mouse exhibit characteristics of early heavy chain rearrangement. J Immunol. 2009;183:452–461. doi: 10.4049/jimmunol.0804060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Nakajima PB, Kiefer K, Price A, Bosma GC, Bosma MJ. Two distinct populations of H chain-edited B cells show differential surrogate L chain dependence. J Immunol. 2009;182:3583–3596. doi: 10.4049/jimmunol.0802533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Lutz J, Müller W, Jäck HM. VH replacement rescues progenitor B cells with two nonproductive VDJ alleles. J Immunol. 2006;177:7007–7014. doi: 10.4049/jimmunol.177.10.7007. [DOI] [PubMed] [Google Scholar]
  • 51.Liu Y, Li L, Mohan C. The role of rearrangement at the second Ig heavy chain locus in maintaining B cell tolerance to DNA. J Immunol. 2008;180:7721–7727. doi: 10.4049/jimmunol.180.11.7721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Prak EL, Weigert M. Light chain replacement: a new model for antibody gene rearrangement. J Exp Med. 1995;182:541–548. doi: 10.1084/jem.182.2.541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Li Y, Louzoun Y, Weigert M. Editing anti-DNA B cells by Vlambdax. J Exp Med. 2004;199:337–346. doi: 10.1084/jem.20031712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Witsch EJ, Cao H, Fukuyama H, Weigert M. Light chain editing generates polyreactive antibodies in chronic graft-versus-host reaction. J Exp Med. 2006;203:1761–1772. doi: 10.1084/jem.20060075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Weiss S, Lehmann K, Cohn M. Monoclonal antibodies to murine immunoglobulin isotypes. Hybridoma. 1983;2:49–54. doi: 10.1089/hyb.1983.2.49. [DOI] [PubMed] [Google Scholar]
  • 56.Kim JY, Kurtz B, Huszar D, Storb U. Crossing the SJL lambda locus into kappa-knockout mice reveals a dysfunction of the lambda 1-containing immunoglobulin receptor in B cell differentiation. EMBO J. 1994;13:827–834. doi: 10.1002/j.1460-2075.1994.tb06325.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Sanchez P, Nadel B, Cazenave PA. V lambda-J lambda rearrangements are restricted within a V-J-C recombination unit in the mouse. Eur J Immunol. 1991;21:907–911. doi: 10.1002/eji.1830210408. [DOI] [PubMed] [Google Scholar]
  • 58.Wardemann H, et al. Predominant autoantibody production by early human B cell precursors. Science. 2003;301:1374–1377. doi: 10.1126/science.1086907. [DOI] [PubMed] [Google Scholar]
  • 59.Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. Sequences of Proteins of Immunological Interest. 1991. (5th ed. Natl Inst Health, Bethesda), DHHS Publ No (NIH) 91-3242. [Google Scholar]
  • 60.Prak EL, Trounstine M, Huszar D, Weigert M. Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance. J Exp Med. 1994;180:1805–1815. doi: 10.1084/jem.180.5.1805. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information
1019389108_sfig02.pdf (392.9KB, pdf)
1019389108_sfig03.tif (10.3MB, tif)
1019389108_sfig04.tif (401.8MB, tif)
1019389108_sfig05.tif (3.5MB, tif)

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES